As of May 23, 2025, DENTSPLY SIRONA Inc (XRAY) reports a Forward P/E of 8.45.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing DENTSPLY SIRONA Inc's Forward P/E to Peers
To better understand DENTSPLY SIRONA Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| DENTSPLY SIRONA Inc (XRAY) | 8.45 |
| Antares Pharma Inc (ATRS) | 51.85 |
| Meridian Bioscience Inc (VIVO) | 39.98 |
| West Pharmaceutical Services Inc (WST) | 32.87 |
| Merit Medical Systems Inc (MMSI) | 28.26 |
| Cooper Companies Inc (COO) | 21.27 |
Compared to its competitors, DENTSPLY SIRONA Inc's Forward P/E is lower than all peers, which may suggest undervaluation or market concerns about future earnings.